LUMO - Lumos Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

LUMO is currently covered by 3 analysts with an average price target of $-3.26. This is a potential upside of $-5.78 (-229.37%) from yesterday's end of day stock price of $2.52.

Lumos Pharma's activity chart (see below) currently has 25 price targets and 32 ratings on display. The stock rating distribution of LUMO is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.83% with an average time for these price targets to be met of 267.8 days.

Highest price target for LUMO is $10, Lowest price target is $10, average price target is $-3.26.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 11-Dec-2023. First documented stock forecast 10-May-2016.

Currently out of the existing stock ratings of LUMO, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10

$7.35 (277.36%)

10

7 months 27 days ago

1/4 (25%)

$7.03 (236.70%)

28

Hold

7

$4.35 (164.15%)

7

1 years 4 months 10 days ago

2/4 (50%)

$2.8 (66.67%)

79

Buy

26

1 years 5 months 4 days ago

2/5 (40%)

$17.95 (222.98%)

182

Buy

28

2 years 5 months 8 days ago

1/3 (33.33%)

$18.49 (194.43%)

148

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LUMO (Lumos Pharma) average time for price targets to be met?

On average it took 267.8 days on average for the stock forecasts to be realized with a an average price target met ratio 64.83

Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on LUMO (Lumos Pharma)?

Peter Lawson works at BARCLAYS and has 15 price targets and 9 ratings on LUMO

Which analyst is the currently most bullish on LUMO (Lumos Pharma)?

Mara Goldstein with highest potential upside - $23.35

Which analyst is the currently most reserved on LUMO (Lumos Pharma)?

Edward White with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?